How to Break Into Defense Health: What Department of War Insiders Want Innovators to Know

Key takeaways
- Defense health is the work of keeping service members healthy, capable, and ready before, during, and after injury. It covers far more than battlefield medicine.
- Start with the Department of War’s (DoW) problem, not your technology. Then figure out where your product will be used, because that decides who you call.
- Small Business Innovation Research (SBIR) awards are one door, not the only one. Research agreements and medical consortia often fit health technology better.
- The people who champion your work are rarely the people who can buy it. Plan for that from day one.
To get a health technology into military use, you need three things: a DoW problem your product solves, a pathway that fits your stage, and relationships with the people who can test it, champion it, and buy it. Those are usually three different groups.
That’s the short version of what a panel of defense health leaders told a room of founders and researchers at the Warfighting Integration Network (WIN) Summit Series in Louisville, Kentucky, on August 11, 2026. We’ve organized their advice here by the questions innovators ask us most.
The panel
- Sean Frisbee (moderator), President, Vertx Partners, and retired Air Force acquisition leader
- Dr. Daniel Zelik, Deputy Director of the U.S. Air Force Research Laboratory (AFRL) Human Effectiveness Directorate (RH)
- Barry Datlof, Chief, Business Development and Commercialization for the Medical Technology Transfer Office, DHA
- Scott Aughenbaugh, Director, Department of the Air Force (DAF) Technology Transfer & Transition (T3)
- Tony Perez, Strategic Advisor, Vertx Partners, and former Air Force pilot
What is defense health?
Defense health is everything that keeps a service member able to do the job: prevention, training, treatment, and recovery.
Frisbee opened with the reason it matters. Aircraft and ships get the attention, but it takes years to train the people who operate them. “That human is really the least replaceable weapon system that we have,” he said. The panel’s question: “How do we make that human more capable?”
Datlof put the Defense Health Agency’s (DHA) scope in one line: “We take care of before, during and after.” That means sleep, nutrition, exercise, and mental training count as much as trauma care.
Zelik explained why the human stays at the center. “Warfighting is a human endeavor. No system, no technology has a stake in the outcome.”
What health technology does the Department of War need?
It depends on who you ask, which is the point. Each organization has a narrower focus than its public language suggests.
For the Air Force’s human performance researchers, Zelik named two broad areas: technologies that build the next generation of warfighter, from new therapeutics to wearables, and human-machine teaming as more operators work alongside autonomous systems. On the medical side, he identified three priorities: en route care for patients being transported, critical care automation, and blood.
DHA looks wider. Datlof said the military health system serves about 9 million people, and that this data can help validate a company’s product when combined with external datasets.
Why should you start with the problem and not your technology?
This is a critical question, and the response is that your technology is probably only part of the answer. Datlof was blunt: “You’re all in love with your technology.” But the necessary approach is to fall in love with the Department’s problem and find the collaborators who complete the solution.
He also explained how the government decides who it trusts. Have you worked with the Department before or built a product that it already buys? New entrants aren’t disqualified, but they have more to prove upfront. “Trust comes from people showing up, not mailing in applications,” he said.
Which funding and partnership pathways are suitable for health technology?
There are more options than most first-time applicants realize. Aughenbaugh recommended the Contracting Cone, an interactive digital tool and public reference graphic created by the Warfighting Acquisition University (WarU) as part of the Adaptive Acquisition Framework that maps every way the Department buys and partners.
A Cooperative Research and Development Agreement (CRADA) is a relationship tool. Its value is access. It lets you test whether your product does what you say it does in the government’s environment, and Aughenbaugh said it can run alongside an SBIR award. Classified work is possible with the right security paperwork in place.
For health care, Datlof named two Other Transaction Authority (OTA) consortia: the Medical Technology Enterprise Consortium (MTEC) and the Medical CBRN Defense Consortium (MCDC), which covers chemical, biological, radiological, and nuclear threats.
One more thing that makes defense health different. Aughenbaugh said the Department often doesn’t want a new health product to become a formal program. It wants to buy it off the shelf.
Is SBIR worth it if you have no defense connections?
Yes, if you have time and you understand what you’re applying to.
Perez’s test is runway. If you have three months of cash, SBIR is not your strategy. It takes longer than that just to get feedback. As one of several funding sources, it can work well.
Zelik’s test is knowledge. He borrowed a poker rule: if you can’t spot the sucker at the table, it’s you. Some SBIR topics are exploratory. Some are written by a scientist with a specific answer in mind, and others come from operational units. They look the same from the outside. “That doesn’t mean don’t play, because there are some tables that are worth playing at,” he said.
The fix is more straightforward than most assume: a conversation. A majority of topics list a technical point of contact and an open window to talk with them. This is your opportunity to understand what they need, not to pitch. Zelik noted that expert reviewers can tell when a proposal was written by AI. “They might not know your company, but they know the tech.”
Who is your customer, and who is your champion?
They’re almost never the same person.
Lab researchers are champions. “I tend to think of our folks as more champions or advocates for your work,” Zelik said. If your product is finished and a unit can buy it, the lab has no role. “If I have a mission unit and something you can buy, go buy it.”
Junior officers and generals are not buyers either. Aughenbaugh said the people who move technology into use sit in the middle. “It’s their action officers. It’s the colonels. It’s the senior materiel leaders.”
His advice for a commercial product with no military testing: find units willing to try it, such as the National Guard, and build evidence before you approach your target customer.
Then start on tech transition early. “You should already be looking at the next bunch of money as soon as you get the first bunch of money,” Perez said. Even a willing buyer needs six months to a year to line up follow-on funding.
Where will your technology be used?
Datlof called this the deciding question: “Where will your technology be used?” Care delivered far forward usually points to U.S. Special Operations Command. Military hospitals and the military medical school point to DHA. Once service members leave active duty, their care moves to the Department of Veterans Affairs, which is a separate agency.
Zelik added a practical filter. Pick the organization where you can find a seasoned government champion, someone who has moved technology into use before and knows where it breaks down.
Where does AI fit in defense health?
“AI is an enabler,” Zelik said, but making it essential to a defense capability is risky. Training is a strong fit because human instructors are still in the loop. For example, a diagnostic that needs connectivity in the back of an aircraft or a makeshift tent is not. The Department is rarely the first adopter, he said, but it wants to be part of the early wave.
What stops promising health technology?
Scale. Aughenbaugh said plenty of companies can deliver two or three strong prototypes and can’t manufacture at volume. Panelists also flagged supply chain rules, so expect to be asked where your components come from.
What if you’re a researcher without a product yet?
You have more ways in than you think. Zelik’s suggestions:
- Send a student. He once funded a professor after meeting that professor’s summer intern.
- Apply for the postdoctoral openings. “I have lots of ads that get virtually no applicants.”
- Join a team. Partner with a group that already works with the lab.
Aughenbaugh pointed to a lightweight, nondisclosure-style CRADA that lets a company and a lab talk openly before a project exists.
Which conferences should you attend?
Datlof’s list: the Military Health System Research Symposium (MHSRS), held each summer in Kissimmee, Florida, for general military health care and devices, plus the BIO conference for biopharmaceuticals and vaccines, and the MTEC annual member meeting. Be especially sure to walk the poster sessions; they show what the Department is funding now.
What can you do in the next 30 days?
Frisbee closed by asking each panelist for one action.
- Get oriented. Perez: Talk to a local resource such as WIN or the Defense Innovation Unit (DIU) OnRamp Hub: Kentucky to build your picture of the market.
- Make a friend. Zelik: Cold emails rarely land. “Find a way to make a friend.” Researchers are most open at conferences.
- Narrow your ask. Aughenbaugh: Tell the people helping you exactly what you need.
- Bring something physical. Datlof: “When somebody literally gives me a prototype, I am more likely to remember that for the rest of my life.”
Map your path into defense health
WIN helps companies and researchers find the right DoW problem, pathway, and people at no cost. We don’t write proposals or guarantee awards, but we guide you through the sometimes confusing and nuanced process of working with the Department of War.
Get in touch with WIN to map your next step.
Photo Credit: Airman 1st Class David Lynn